When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.

Detalles Bibliográficos
Publicado en:American Journal of Bioethics Vol. 20; no. 4; pp. 118 - 121
Autores principales: Matsler, Jeff, Young, Jamila M.
Formato: Journal Article
Publicado: Taylor & Francis Ltd Apr2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149496543&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 149496543
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15265161
        FKZ
      jtl: American Journal of Bioethics
      issn: 15265161
      maglogo: N
    pubinfo:
      dt: Apr2020
      vid: 20
      iid: 4
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        149496543
        10.1080/15265161.2020.1730491
        149496543
      ppf: 118
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.
      aug:
        au:
          Matsler, Jeff
          Young, Jamila M.
        affil: WellStar Healthcare System
      sug:
        subj:
          Lupus Erythematosus, Systemic Diagnosis
          Age of Onset In Infancy and Childhood
          Research, Medical Ethical Issues
          Research Subject Recruitment Ethical Issues
          Research Subjects In Infancy and Childhood
          United States Food and Drug Administration Standards
          Risk Assessment
          Child
          Child: 6-12 years
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N